scispace - formally typeset
D

David Edgar

Researcher at Trinity College, Dublin

Publications -  7
Citations -  608

David Edgar is an academic researcher from Trinity College, Dublin. The author has contributed to research in topics: Common variable immunodeficiency & Asymptomatic carrier. The author has an hindex of 5, co-authored 7 publications receiving 351 citations. Previous affiliations of David Edgar include Belfast Health and Social Care Trust.

Papers
More filters
Journal ArticleDOI

The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity

TL;DR: Clinical criteria for a large number of IEI that were designed in expert panels with an external review are presented and implemented for novel entries and verification of existing data sets from 2014, yielding a substantial refinement.
Journal ArticleDOI

Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans

Paul Tuijnenburg, +157 more
TL;DR: It is shown that heterozygous loss‐of‐function variants in NFKB1 are the most common known monogenic cause of CVID, which results in a temporally progressive defect in the formation of immunoglobulin‐producing B cells.
Journal ArticleDOI

Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations.

Julian Thalhammer, +313 more
TL;DR: In this paper, age-related initial presenting manifestations of Inborn errors of immunity (IEI) including different IEI disease cohorts were analyzed. But, although increased infection susceptibility is a well-known initial IEI manifestation, less is known about the frequency of other presenting manifestations.
Journal ArticleDOI

C1 inhibitor deficiency: 2014 United Kingdom consensus document

TL;DR: An updated 2014 United Kingdom consensus document for the management of C1 inhibitor‐deficient patients, representing a joint venture between the United Kingdom Primary Immunodeficiency Network and Hereditary Angioedema UK is presented.
Journal ArticleDOI

Specific antibody deficiencies in clinical practice

TL;DR: Assessment of immunity and therapeutic actions to deal with SADs need to be based on clinical evidence rather than solely on arbitrarily defined antibody responses.